Northside Hospital - Gwinnett — Lawrenceville, Georgia

Northside Hospital - Gwinnett is a clinical research site located in Lawrenceville, Georgia, United States 30046.

Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.

Northside Hospital - Gwinnett has participated in 59 clinical trials with 42 currently active.

Therapeutic areas: Myelodysplastic Syndromes (MDS), Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma.

Sponsors: National Heart, Lung, and Blood Institute (NHLBI), SWOG Cancer Research Network, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lawrenceville

Browse all research sites in Georgia · View every site in Lawrenceville

Sponsor Feasibility Report

Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northside Hospital - Gwinnett?

Northside Hospital - Gwinnett has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northside Hospital - Gwinnett conducted?

Northside Hospital - Gwinnett has 59 clinical trials on record, with 42 currently active. Their work covers Myelodysplastic Syndromes (MDS), Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma.

Is Northside Hospital - Gwinnett accredited by Crixeo Clinical Trials?

Northside Hospital - Gwinnett has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northside Hospital - Gwinnett?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.